Insider Transactions in Q4 2024 at Arcutis Biotherapeutics, Inc. (ARQT)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 19
2024
|
Masaru Matsuda Officer |
SELL
Open market or private sale
|
Direct |
1,775
-0.97%
|
$15,975
$9.68 P/Share
|
|
Nov 18
2024
|
Masaru Matsuda Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,875
+2.59%
|
-
|
|
Nov 15
2024
|
Patrick Burnett Officer |
SELL
Open market or private sale
|
Direct |
100
-0.08%
|
$1,000
$10.03 P/Share
|
|
Nov 15
2024
|
Patrick Burnett Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
100
+0.08%
|
-
|
|
Nov 14
2024
|
Patrick Burnett Officer |
SELL
Open market or private sale
|
Direct |
69,126
-20.39%
|
$691,260
$10.29 P/Share
|
|
Nov 14
2024
|
Patrick Burnett Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,377
+11.11%
|
-
|
|
Nov 11
2024
|
Terrie Curran Director |
SELL
Open market or private sale
|
Direct |
8,687
-46.14%
|
$86,870
$10.85 P/Share
|
|
Nov 04
2024
|
Patrick Burnett Officer |
SELL
Open market or private sale
|
Direct |
15,441
-7.92%
|
$123,528
$8.68 P/Share
|
|
Nov 04
2024
|
Todd Franklin Watanabe Director |
SELL
Open market or private sale
|
Direct |
13,871
-1.64%
|
$110,968
$8.68 P/Share
|
|
Nov 04
2024
|
Masaru Matsuda Officer |
SELL
Open market or private sale
|
Direct |
5,015
-2.74%
|
$40,120
$8.68 P/Share
|
|
Nov 01
2024
|
Howard G. Welgus Director |
SELL
Open market or private sale
|
Direct |
10,000
-5.5%
|
$80,000
$8.65 P/Share
|
|
Oct 02
2024
|
Larry Todd Edwards SVP Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
3,725
-2.65%
|
$37,250
$10.01 P/Share
|
|
Oct 01
2024
|
Howard G. Welgus Director |
SELL
Open market or private sale
|
Direct |
10,000
-5.21%
|
$90,000
$9.26 P/Share
|